These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
288 related items for PubMed ID: 7545653
1. Two distinct patterns of peritoneal involvement shown by in vitro and in vivo ovarian cancer dissemination models. Kishikawa T, Sakamoto M, Ino Y, Kubushiro K, Nozawa S, Hirohashi S. Invasion Metastasis; 1995; 15(1-2):11-21. PubMed ID: 7545653 [Abstract] [Full Text] [Related]
2. An experimental model for ovarian tumor invasion of cultured mesothelial cell monolayer. Sawada M, Shii J, Akedo H, Tanizawa O. Lab Invest; 1994 Mar; 70(3):333-8. PubMed ID: 8145527 [Abstract] [Full Text] [Related]
3. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo. Zhang J, Wang B. Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393 [Abstract] [Full Text] [Related]
4. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells. Ogura T, Kobayashi H, Ueoka Y, Okugawa K, Kato K, Hirakawa T, Hashimoto S, Taniguchi S, Wake N, Nakano H. Clin Cancer Res; 2006 Sep 01; 12(17):5216-23. PubMed ID: 16951241 [Abstract] [Full Text] [Related]
5. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma. Kawajiri H, Yashiro M, Shinto O, Nakamura K, Tendo M, Takemura S, Node M, Hamashima Y, Kajimoto T, Sawada T, Ohira M, Hirakawa K. Clin Cancer Res; 2008 May 01; 14(9):2850-60. PubMed ID: 18451253 [Abstract] [Full Text] [Related]
9. Novel screening technique for dissemination potential of ovarian cancer cells to peritoneum. Fujimoto J, Hori M, Ichigo S, Morishita S, Tamaya T. Invasion Metastasis; 1996 May 01; 16(6):302-7. PubMed ID: 9371229 [Abstract] [Full Text] [Related]
10. Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis. Sandoval P, Jiménez-Heffernan JA, Rynne-Vidal Á, Pérez-Lozano ML, Gilsanz Á, Ruiz-Carpio V, Reyes R, García-Bordas J, Stamatakis K, Dotor J, Majano PL, Fresno M, Cabañas C, López-Cabrera M. J Pathol; 2013 Dec 01; 231(4):517-31. PubMed ID: 24114721 [Abstract] [Full Text] [Related]
13. Alendronate inhibits intraperitoneal dissemination in in vivo ovarian cancer model. Hashimoto K, Morishige K, Sawada K, Tahara M, Kawagishi R, Ikebuchi Y, Sakata M, Tasaka K, Murata Y. Cancer Res; 2005 Jan 15; 65(2):540-5. PubMed ID: 15695397 [Abstract] [Full Text] [Related]
16. HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells. Suzuki N, Aoki D, Tamada Y, Susumu N, Orikawa K, Tsukazaki K, Sakayori M, Suzuki A, Fukuchi T, Mukai M, Kojima-Aikawa K, Ishida I, Nozawa S. Gynecol Oncol; 2004 Nov 15; 95(2):290-8. PubMed ID: 15491748 [Abstract] [Full Text] [Related]
17. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer]. Ding YL, Zhang JL, Tang SF, Fu QY, Li ZT. Zhonghua Yi Xue Za Zhi; 2008 Jan 15; 88(3):202-5. PubMed ID: 18361822 [Abstract] [Full Text] [Related]